RNA - Avidity Biosciences  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RNA is currently covered by 12 analysts with an average price target of $91.05. This is a potential upside of $18.19 (24.97%) from yesterday's end of day stock price of $72.86.

Avidity Biosciences 's activity chart (see below) currently has 79 price targets and 92 ratings on display. The stock rating distribution of RNA is 73.33% BUY and 26.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.96% with an average time for these price targets to be met of 391.53 days.

Highest price target for RNA is $96, Lowest price target is $59, average price target is $70.91.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 11-Nov-2025. First documented stock forecast 07-Jul-2020.

Currently out of the existing stock ratings of RNA, 22 are a BUY (73.33%), 8 are a HOLD (26.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 28-Oct-2025

$72

$-0.86 (-1.18%)

$72

3 months 12 days ago
(11-Nov-2025)

14/16 (87.5%)

$1.3 (1.84%)

249

Hold Since 29-Oct-2025

$74

$1.14 (1.56%)

$78

3 months 25 days ago
(29-Oct-2025)

2/4 (50%)

$4.35 (6.25%)

439

Hold Since 28-Oct-2025

$72

$-0.86 (-1.18%)

$61

3 months 26 days ago
(28-Oct-2025)

4/4 (100%)

$2.07 (2.96%)

227

Hold Since 27-Oct-2025

$72

$-0.86 (-1.18%)

3 months 27 days ago
(27-Oct-2025)

3/3 (100%)

$2 (2.86%)

969

Hold Since 27-Oct-2025

$65

$-7.86 (-10.79%)

$65

3 months 27 days ago
(27-Oct-2025)

17/18 (94.44%)

$-5 (-7.14%)

255

Show more analysts

Please expand the browser size to see the chart

What is RNA (Avidity Biosciences ) average time for price targets to be met?

On average it took 391.53 days on average for the stock forecasts to be realized with a an average price target met ratio 88.96

Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on RNA (Avidity Biosciences )?

Andrew Fein works at HC WAINWRIGHT and has 18 price targets and 18 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences )?

Eric Schmidt with highest potential upside - $23.14

Which analyst is the currently most reserved on RNA (Avidity Biosciences )?

Judah Frommer with lowest potential downside - -$42.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?